A large trial of a drug to treat dementia caused by Alzheimer’s disease has ended in failure after people receiving the treatment showed no significant improvements to those taking a placebo. The failure of the much anticipated drug, which showed promise in earlier results, is being seen as a disappointing setback, but not the end […]
